272 related articles for article (PubMed ID: 25531812)
1. Rarity of the Alzheimer disease-protective APP A673T variant in the United States.
Wang LS; Naj AC; Graham RR; Crane PK; Kunkle BW; Cruchaga C; Murcia JD; Cannon-Albright L; Baldwin CT; Zetterberg H; Blennow K; Kukull WA; Faber KM; Schupf N; Norton MC; Tschanz JT; Munger RG; Corcoran CD; Rogaeva E; ; Lin CF; Dombroski BA; Cantwell LB; Partch A; Valladares O; Hakonarson H; St George-Hyslop P; Green RC; Goate AM; Foroud TM; Carney RM; Larson EB; Behrens TW; Kauwe JS; Haines JL; Farrer LA; Pericak-Vance MA; Mayeux R; Schellenberg GD; ; Albert MS; Albin RL; Apostolova LG; Arnold SE; Barber R; Barmada M; Barnes LL; Beach TG; Becker JT; Beecham GW; Beekly D; Bennett DA; Bigio EH; Bird TD; Blacker D; Boeve BF; Bowen JD; Boxer A; Burke JR; Buxbaum JD; Cairns NJ; Cao C; Carlson CS; Carroll SL; Chui HC; Clark DG; Cribbs DH; Crocco EA; DeCarli C; DeKosky ST; Demirci FY; Dick M; Dickson DW; Duara R; Ertekin-Taner N; Fallon KB; Farlow MR; Ferris S; Frosch MP; Galasko DR; Ganguli M; Gearing M; Geschwind DH; Ghetti B; Gilbert JR; Glass JD; Graff-Radford NR; Growdon JH; Hamilton RL; Hamilton-Nelson KL; Harrell LE; Head E; Honig LS; Hulette CM; Hyman BT; Jarvik GP; Jicha GA; Jin LW; Jun G; Jun G; Kamboh MI; Karydas A; Kaye JA; Kim R; Koo EH; Kowall NW; Kramer JH; LaFerla FM; Lah JJ; Leverenz JB; Levey AI; Li G; Lieberman AP; Lopez OL; Lunetta KL; Lyketsos CG; Mack WJ; Marson DC; Martin ER; Martiniuk F; Mash DC; Masliah E; McCormick WC; McCurry SM; McDavid AN; McKee AC; Mesulam WM; Miller BL; Miller CA; Miller JW; Montine TJ; Morris JC; Murrell JR; Olichney JM; Parisi JE; Perry W; Peskind E; Petersen RC; Pierce A; Poon WW; Potter H; Quinn JF; Raj A; Raskind M; Reiman EM; Reisberg B; Reitz C; Ringman JM; Roberson ED; Rosen HJ; Rosenberg RN; Sano M; Saykin AJ; Schneider JA; Schneider LS; Seeley WW; Smith AG; Sonnen JA; Spina S; Stern RA; Tanzi RE; Thornton-Wells TA; Trojanowski JQ; Troncoso JC; Tsuang DW; Van Deerlin VM; Van Eldik LJ; Vardarajan BN; Vinters HV; Vonsattel JP; Weintraub S; Welsh-Bohmer KA; Williamson J; Wishnek S; Woltjer RL; Wright CB; Younkin SG; Yu CE; Yu L
JAMA Neurol; 2015 Feb; 72(2):209-16. PubMed ID: 25531812
[TBL] [Abstract][Full Text] [Related]
2. Protective Alzheimer's disease-associated APP A673T variant predominantly decreases sAPPβ levels in cerebrospinal fluid and 2D/3D cell culture models.
Wittrahm R; Takalo M; Kuulasmaa T; Mäkinen PM; Mäkinen P; Končarević S; Fartzdinov V; Selzer S; Kokkola T; Antikainen L; Martiskainen H; Kemppainen S; Marttinen M; Jeskanen H; Rostalski H; Rahunen E; Kivipelto M; Ngandu T; Natunen T; Lambert JC; Tanzi RE; Kim DY; Rauramaa T; Herukka SK; Soininen H; Laakso M; Pike I; Leinonen V; Haapasalo A; Hiltunen M
Neurobiol Dis; 2023 Jun; 182():106140. PubMed ID: 37120095
[TBL] [Abstract][Full Text] [Related]
3. Absence of A673T variant in APP gene indicates an alternative protective mechanism contributing to longevity in Chinese individuals.
Liu YW; He YH; Zhang YX; Cai WW; Yang LQ; Xu LY; Kong QP
Neurobiol Aging; 2014 Apr; 35(4):935.e11-2. PubMed ID: 24126161
[TBL] [Abstract][Full Text] [Related]
4. Investigation of an amyloid precursor protein protective mutation (A673T) in a North American case-control sample of late-onset Alzheimer's disease.
Bamne MN; Demirci FY; Berman S; Snitz BE; Rosenthal SL; Wang X; Lopez OL; Kamboh MI
Neurobiol Aging; 2014 Jul; 35(7):1779.e15-6. PubMed ID: 24529499
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of Alzheimer disease protection by the A673T allele of amyloid precursor protein.
Maloney JA; Bainbridge T; Gustafson A; Zhang S; Kyauk R; Steiner P; van der Brug M; Liu Y; Ernst JA; Watts RJ; Atwal JK
J Biol Chem; 2014 Nov; 289(45):30990-1000. PubMed ID: 25253696
[TBL] [Abstract][Full Text] [Related]
6. Decreased plasma β-amyloid in the Alzheimer's disease APP A673T variant carriers.
Martiskainen H; Herukka SK; Stančáková A; Paananen J; Soininen H; Kuusisto J; Laakso M; Hiltunen M
Ann Neurol; 2017 Jul; 82(1):128-132. PubMed ID: 28556232
[TBL] [Abstract][Full Text] [Related]
7. The APP A673T frequency differs between Nordic countries.
Mengel-From J; Jeune B; Pentti T; McGue M; Christensen K; Christiansen L
Neurobiol Aging; 2015 Oct; 36(10):2909.e1-4. PubMed ID: 26239177
[TBL] [Abstract][Full Text] [Related]
8. Absence of A673T amyloid-β precursor protein variant in Alzheimer's disease and other neurological diseases.
Ting SK; Chong MS; Kandiah N; Hameed S; Tan L; Au WL; Prakash KM; Pavanni R; Lee TS; Foo JN; Bei JX; Yu XQ; Liu JJ; Zhao Y; Lee WL; Tan EK
Neurobiol Aging; 2013 Oct; 34(10):2441.e7-8. PubMed ID: 23652020
[TBL] [Abstract][Full Text] [Related]
9. The Protective A673T Mutation of Amyloid Precursor Protein (APP) in Alzheimer's Disease.
Xia Q; Yang X; Shi J; Liu Z; Peng Y; Wang W; Li B; Zhao Y; Xiao J; Huang L; Wang D; Gao X
Mol Neurobiol; 2021 Aug; 58(8):4038-4050. PubMed ID: 33914267
[TBL] [Abstract][Full Text] [Related]
10. Insertion of the Icelandic Mutation (A673T) by Prime Editing: A Potential Preventive Treatment for Familial and Sporadic Alzheimer's Disease.
Tremblay G; Rousseau J; Mbakam CH; Tremblay JP
CRISPR J; 2022 Feb; 5(1):109-122. PubMed ID: 35133877
[TBL] [Abstract][Full Text] [Related]
11. Amyloid precursor protein (APP) A673T mutation in the elderly Finnish population.
Kero M; Paetau A; Polvikoski T; Tanskanen M; Sulkava R; Jansson L; Myllykangas L; Tienari PJ
Neurobiol Aging; 2013 May; 34(5):1518.e1-3. PubMed ID: 23102935
[TBL] [Abstract][Full Text] [Related]
12. The protective mutation A673T in amyloid precursor protein gene decreases Aβ peptides production for 14 forms of Familial Alzheimer's Disease in SH-SY5Y cells.
Guyon A; Rousseau J; Lamothe G; Tremblay JP
PLoS One; 2020; 15(12):e0237122. PubMed ID: 33370284
[TBL] [Abstract][Full Text] [Related]
13. Generation of a human induced pluripotent stem cell line (UEFi003-A) carrying heterozygous A673T variant in amyloid precursor protein associated with a reduced risk of Alzheimer's disease.
Rolova T; Wu YC; Koskuvi M; Voutilainen J; Sonninen TM; Kuusisto J; Laakso M; Hämäläinen RH; Koistinaho J; Lehtonen Š
Stem Cell Res; 2020 Oct; 48():101968. PubMed ID: 32911327
[TBL] [Abstract][Full Text] [Related]
14. Generation of a human induced pluripotent stem cell line from a patient with a rare A673T variant in amyloid precursor protein gene that reduces the risk for Alzheimer's disease.
Lehtonen Š; Höytyläinen I; Voutilainen J; Sonninen TM; Kuusisto J; Laakso M; Hämäläinen RH; Oksanen M; Koistinaho J
Stem Cell Res; 2018 Jul; 30():96-99. PubMed ID: 29807259
[TBL] [Abstract][Full Text] [Related]
15. Clinical and neuropathological features of the arctic APP gene mutation causing early-onset Alzheimer disease.
Basun H; Bogdanovic N; Ingelsson M; Almkvist O; Näslund J; Axelman K; Bird TD; Nochlin D; Schellenberg GD; Wahlund LO; Lannfelt L
Arch Neurol; 2008 Apr; 65(4):499-505. PubMed ID: 18413473
[TBL] [Abstract][Full Text] [Related]
16. Association of Early-Onset Alzheimer Disease With Elevated Low-Density Lipoprotein Cholesterol Levels and Rare Genetic Coding Variants of APOB.
Wingo TS; Cutler DJ; Wingo AP; Le NA; Rabinovici GD; Miller BL; Lah JJ; Levey AI
JAMA Neurol; 2019 Jul; 76(7):809-817. PubMed ID: 31135820
[TBL] [Abstract][Full Text] [Related]
17. A founder mutation in presenilin 1 causing early-onset Alzheimer disease in unrelated Caribbean Hispanic families.
Athan ES; Williamson J; Ciappa A; Santana V; Romas SN; Lee JH; Rondon H; Lantigua RA; Medrano M; Torres M; Arawaka S; Rogaeva E; Song YQ; Sato C; Kawarai T; Fafel KC; Boss MA; Seltzer WK; Stern Y; St George-Hyslop P; Tycko B; Mayeux R
JAMA; 2001 Nov; 286(18):2257-63. PubMed ID: 11710891
[TBL] [Abstract][Full Text] [Related]
18. Association studies testing for risk for late-onset Alzheimer's disease with common variants in the beta-amyloid precursor protein (APP).
Nowotny P; Simcock X; Bertelsen S; Hinrichs AL; Kauwe JS; Mayo K; Smemo S; Morris JC; Goate A
Am J Med Genet B Neuropsychiatr Genet; 2007 Jun; 144B(4):469-74. PubMed ID: 17427190
[TBL] [Abstract][Full Text] [Related]
19. Clinical comparison of Alzheimer's disease in pedigrees with the codon 717 Val-->Ile mutation in the amyloid precursor protein gene.
Mullan M; Tsuji S; Miki T; Katsuya T; Naruse S; Kaneko K; Shimizu T; Kojima T; Nakano I; Ogihara T
Neurobiol Aging; 1993; 14(5):407-19. PubMed ID: 8247223
[TBL] [Abstract][Full Text] [Related]
20. Fine-mapping of the human leukocyte antigen locus as a risk factor for Alzheimer disease: A case-control study.
Steele NZ; Carr JS; Bonham LW; Geier EG; Damotte V; Miller ZA; Desikan RS; Boehme KL; Mukherjee S; Crane PK; Kauwe JS; Kramer JH; Miller BL; Coppola G; Hollenbach JA; Huang Y; Yokoyama JS
PLoS Med; 2017 Mar; 14(3):e1002272. PubMed ID: 28350795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
